CRUN
Menu

Learn Why We are one of the Best Laboratory Around

We have a strong presence worldwide with the goal of
We have a strong presence worldwide
with the goal of
We have a
strong presence
worldwide with the
goal of
Advanced Research Unit

The CRUN fosters an environment encouraging innovation and diligence among the staff and promoting career development.

Recognized Worldwide

The CRUN is a recognized research unit within the worldwide research community and offers good facilities for clinical trials.

Use Of ICH-GCP Regulations.

The CRUN operates in accordance with ICH-GCP regulations while conducting clinical trials and in its interactions with the community and study participants, the sponsor(s), and all other stakeholders.

Qualified Doctors And Researchers

Our self motivated and dedicated team of doctors and researchers has a major role to play in our success and growth and has provided us with an opportunity to deliver outstanding services.

Partnership

The CRUN promotes international collaboration with recognized research institutions in Africa and around the world for the exchange of experiences, technology transfers, and continuous quality improvement in all operations.

Awards & Honors

The World Health Organization (WHO) has recognized our RTS,S/AS01 (RTS,S) malaria vaccine and recommended that it be widely distributed to children in Sub-Saharan Africa and other high-risk areas.

Play Video
We are specialized in different fields such as .
We are specialized
in different
fields such as
.

Our Vision

In the next 10 years, the CRUN will become one of the major research and training center in sub-Saharan Africa, participating to seminal work for formulating and orienting African public health strategies and programs, and providing competent human resources in the field of health

RESEARCH

The epidemiology of malaria in sub-Saharan Africa is changing, and this is partly explained by the major increasing in mobilization of funding and at the scaling up of interventions such as the deployment of artemisinin-based combinations (ACT) or long-lasting insecticidal nets (LLIN). The opportunities for the development of new drugs and vaccines for malaria control look brighter now than 10 years ago. However, despite these early successes it is still unclear how this trend will be maintained and what new tools are needed for the (almost) complete elimination of malaria as a public health problem.

Besides malaria, currently the main research subject, the activity of the CRUN will gradually expand to other diseases including bacterial infections, tuberculosis, HIV, schistosomiases and other neglected diseases. This will be achieved by developing a rigorous setting staffed with competent researchers/technicians in which high quality clinical research can be carried out. The CRUN should also become an active member of existing networks/consortia to increase its visibility and foster new collaborations.
 

TRAINING

The CRUN aims at becoming a major training center in the field of clinical research by attracting junior scientists, not only from Africa but also from other continents, who will learn by actively participating to ongoing research projects. The CRUN will also attract African junior scientists and will support them in obtaining high education degrees (MSc, PhD) in collaboration with Southern and Northern academic institutions. Some of them will be retained as core staff. In addition, the CRUN will develop a training program targeted to health professionals willing to acquire the clinical expertise on the management of tropical diseases.